Future perspectives of personalized weight loss interventions based on nutrigenetic, epigenetic, and metagenomic data

Journal of Nutrition

Volumn 146, Issue 4, 2016, Pages 905S-912S

  Goni, Leticia ^a   Cuervo, Marta ^a,b,c   Milagro, Fermín I ^a,b   Martínez, J Alfredo ^a,b,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c IdiSNA Navarra Institute for Health Research   (Spain)

Author keywords

Epigenetics; Gut microbiota; Nutrigenetics; Obesity; Personalized nutrition

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 2 RECEPTOR; ENDOCANNABINOID; FTO PROTEIN; GASTRIC INHIBITORY POLYPEPTIDE; LEPTIN; MELATONIN; MELATONIN 4 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SEROTONIN 2 RECEPTOR; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADIPOSE TISSUE; ALLELE; APPETITE; ARTICLE; CALORIC RESTRICTION; CHRONIC DISEASE; DIET THERAPY; DNA POLYMORPHISM; ENERGY EXPENDITURE; EPIGENETICS; FAT INTAKE; FOOD INTAKE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HUMAN; HYPOTHALAMUS; INFLAMMATION; INTESTINE ABSORPTION; INTESTINE FLORA; LIPID METABOLISM; LIPID STORAGE; METABOLIC RATE; METAGENOMICS; NUTRIGENETICS; OBESITY; PERSONALIZED NUTRITION; SATIETY; WEIGHT REDUCTION;

EID: 84963815239     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.218354     Document Type: Article

References (94)

1. Simopoulos AP. Nutrigenetics/Nutrigenomics. Annu Rev Public Health 2010;31:53-68.
2. San-Cristobal R, Milagro FI, Martinez JA. Future challenges and present ethical considerations in the use of personalized nutrition based on genetic advice. J Acad Nutr Diet 2013;113:1447-54.
3. Skirton H, Goldsmith L, Jackson L, O'Connor A. Direct to consumer genetic testing: A systematic review of position statements, policies and recommendations. Clin Genet 2012;82:210-8.
4. Abete I, Astrup A, Martinez JA, Thorsdottir I, Zulet MA. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev 2010;68:214-31.
5. Martínez J, Milagro FI. Genetics of weight loss: A basis for personalized obesity management. Trends Food Sci Technol 2015;42:97-115.
6. Milagro FI, Mansego ML, De Miguel C, Martinez JA. Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives. Mol Aspects Med 2013;34:782-812.
7. Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014;20:16079-94.
8. Min J, Chiu DT, Wang Y. Variation in the heritability of body mass index based on diverse twin studies: a systematic review. Obes Rev 2013;14:871-82.
9. El-Sayed Moustafa JS, Froguel P. From obesity genetics to the future of personalized obesity therapy. Nat Rev Endocrinol 2013;9:402-13.
10. Matarese LE, Pories WJ. Adult weight loss diets: Metabolic effects and outcomes. Nutr Clin Pract 2014;29:759-67.
11. Collins S, Surwit RS. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog Horm Res 2001;56:309-28.
12. Lee JS, Kawakubo K, Inoue S, Akabayashi A. Effect of beta(3)-adrenergic receptor gene polymorphism on body weight change in middle-aged, overweight women. Environ Health Prev Med 2006;11:69-74.
13. Yamakita M, Ando D, Tang S, Yamagata Z. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with weight changes in obese Japanese men: A 4-year follow-up study. J Physiol Anthropol 2010;29:133-9.
14. Tchernof A, Starling RD, Turner A, Shuldiner AR, Walston JD, Silver K, Poehlman ET. Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Diabetes 2000;49:1709-13.
15. Sakane N, Yoshida T, Umekawa T, Kogure A, Kondo M. Beta2-adrenoceptor gene polymorphism and obesity. Lancet 1999;353:1976.
16. Argilés JM, Busquets S, Lopez-Soriano FJ. The role of uncoupling proteins in pathophysiological states. Biochem Biophys Res Commun 2002;293:1145-52.
17. Cha MH, Shin HD, Kim KS, Lee BH, Yoon Y. The effects of uncoupling protein 3 haplotypes on obesity phenotypes and very low-energy dietinduced changes among overweight Korean female subjects. Metabolism 2006;55:578-86.
18. Yoon Y, Park BL, Cha MH, Kim KS, Cheong HS, Choi YH, Shin HD. Effects of genetic polymorphisms of UCP2 and UCP3 on very low calorie diet-induced body fat reduction in Korean female subjects. Biochem Biophys Res Commun 2007;359:451-6.
19. Nagai N, Sakane N, Kotani K, Hamada T, Tsuzaki K, Moritani T. Uncoupling protein 1 gene-3826 A/G polymorphism is associated with weight loss on a short-term, controlled-energy diet in young women. Nutr Res 2011;31:255-61.
20. De Luis DA, Aller R, Izaola O, De La Fuente B, Conde R, Eiros Bouza JM. Relation of-55CT polymorphism of UCP3 gene with weight loss and metabolic changes after a high monounsaturated fat diet in obese non diabetic patients. Eur Rev Med Pharmacol Sci 2013;17:2810-5.
21. Srinivasan V, Ohta Y, Espino J, Pariente JA, Rodriguez AB, Mohamed M, Zakaria R. Metabolic syndrome, its pathophysiology and the role of melatonin. Recent Pat Endocr Metab Immune Drug Discov 2013;7:11-25.
22. Peter I, McCaffery JM, Kelley-Hedgepeth A, Hakonarson H, Reis S, Wagenknecht LE, Kopin AS, Huggins GS., Genetics Subgroup of the Look AHEAD Study. Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial. Obesity (Silver Spring) 2012;20:1675-82.
23. Mirzaei K, Xu M, Qi Q, de Jonge L, Bray GA, Sacks F, Qi L. Variants in glucose-and circadian rhythm-related genes affect the response of energy expenditure to weight-loss diets: the POUNDS LOST Trial. Am J Clin Nutr 2014;99:392-9.
24. Goni L, Cuervo M, Milagro FI, Martinez JA. Gene-gene interplay and gene-diet interactions involving the MTNR1B rs10830963 variant with body weight loss. J Nutrigenet Nutrigenomics 2015;7:230-40.
25. Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, Kahn SE, Knowler WC, Florez JC, Franks PW., Diabetes Prevention Program Research Group. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program. Diabetes Care 2012;35:363-6.
26. Santos MJL. Leptin-melanocortin system, body weight regulation and obesity. Rev Med Chil 2009;137:1225-34.
27. Sáinz N, Barrenetxe J, Moreno-Aliaga MJ, Martinez JA. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism 2015;64:35-46.
28. Mammès O, Betoulle D, Aubert R, Giraud V, Tuzet S, Petiet A, Colas-Linhart N, Fumeron F. Novel polymorphisms in the 5' region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes 1998;47:487-9.
29. Zacharova J, Chiasson JL, Laakso M. Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance. Obes Res 2005;13:501-6.
30. de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R. Influence of Lys656Asn polymorphism of leptin receptor gene on leptin response secondary to two hypocaloric diets: a randomized clinical trial. Ann Nutr Metab 2008;52:209-14.
31. Pan Q, Delahanty LM, Jablonski KA, Knowler WC, Kahn SE, Florez JC, Franks PW, Diabetes Prevention Program Research Group. Variation at the melanocortin 4 receptor gene and response to weight-loss interventions in the diabetes prevention program. Obesity (Silver Spring) 2013;21:E520-6.
32. Jääskeläinen T, Paananen J, Lindstrom J, Eriksson JG, Tuomilehto J, Uusitupa M., Finnish Diabetes Prevention Study Group. Genetic predisposition to obesity and lifestyle factors-the combined analyses of twenty-six known BMI-and fourteen known waist:hip ratio (WHR)-associated variants in the Finnish Diabetes Prevention Study. Br J Nutr 2013;110:1856-65.
33. Nelson DL, Gehlert DR. Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 2006;29:49-60.
34. Cameron JD, Riou ME, Tesson F, Goldfield GS, Rabasa-Lhoret R, Brochu M, Doucet E. The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women. Appetite 2013;60:111-6.
35. Pooley EC, Fairburn CG, Cooper Z, Sodhi MS, Cowen PJ, Harrison PJA. 5-HT2C receptor promoter polymorphism (HTR2C-759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes. Am J Med Genet B Neuropsychiatr Genet 2004;126B:124-7.
36. Watkins BA, Kim J. The endocannabinoid system: directing eating behavior and macronutrient metabolism. Front Psychol 2014;5:1506.
37. de Luis D, Aller R, Izaola O, Conde R, de la Fuente B, Gonzalez Sagrado M. Genetic variation in the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and their influence on weight loss and insulin resistance under a high monounsaturated fat hypocaloric diet. J Diabetes Complications 2013;27:235-9.
38. Ketterer C, Heni M, Stingl K, Tschritter O, Linder K, Wagner R, Machicao F, Haring HU, Preissl H, Staiger H, et al. Polymorphism rs3123554 in CNR2 reveals gender-specific effects on body weight and affects loss of body weight and cerebral insulin action. Obesity (Silver Spring) 2014;22:925-31.
39. Galbete C, Toledo E, Martinez-Gonzalez MA, Martinez JA, Guillen-Grima F, Marti A. Pro12Ala variant of the PPARG2 gene increases body mass index: An updated meta-analysis encompassing 49,092 subjects. Obesity (Silver Spring) 2013;21:1486-95.
40. Verhoef SP, Camps SG, Bouwman FG, Mariman EC, Westerterp KR. Genetic predisposition, dietary restraint and disinhibition in relation to short and long-term weight loss. Physiol Behav 2014;128:247-51.
41. Basile KJ, Johnson ME, Xia Q, Grant SF. Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies. Int J Endocrinol 2014;2014:769671.
42. Grau K, Cauchi S, Holst C, Astrup A, Martinez JA, Saris WH, Blaak EE, Oppert JM, Arner P, Rossner S, et al. TCF7L2 rs7903146-macronutrient interaction in obese individuals' responses to a 10-wk randomized hypoenergetic diet. Am J Clin Nutr 2010;91:472-9.
43. Haupt A, Thamer C, Heni M, Ketterer C, Machann J, Schick F, Machicao F, Stefan N, Claussen CD, Haring HU, et al. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes. Diabetes 2010;59:747-50.
44. Mattei J, Qi Q, Hu FB, Sacks FM, Qi L. TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention. Am J Clin Nutr 2012;96:1129-36.
45. Heni M, Herzberg-Schafer S, Machicao F, Haring HU, Fritsche A. Dietary fiber intake modulates the association between variants in TCF7L2 and weight loss during a lifestyle intervention. Diabetes Care 2012;35:e24-2012.
46. Speakman JR. Functional analysis of seven genes linked to body mass index and adiposity by genome-wide association studies: a review. Hum Hered 2013;75:57-79.
47. Qi Q, Bray GA, Hu FB, Sacks FM, Qi L. Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial. Am J Clin Nutr 2012;95:506-13.
48. Aberle J, Evans D, Beil FU, Seedorf U. A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet. Clin Genet 2005;68:152-4.
49. Adamo KB, Dent R, Langefeld CD, Cox M, Williams K, Carrick KM, Stuart JS, Sundseth SS, Harper ME, McPherson R, Tesson F. Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity (Silver Spring) 2007;15:1068-75.
50. Ruiz JR, Larrarte E, Margareto J, Ares R, Alkorta P, Labayen I. Preliminary findings on the role of PLIN1 polymorphisms on body composition and energy metabolism response to energy restriction in obese women. Br J Nutr 2011;106:486-90.
51. Corella D, Qi L, Sorli JV, Godoy D, Portoles O, Coltell O, Greenberg AS, Ordovas JM. Obese subjects carrying the 11482G>A polymorphism at the perilipin locus are resistant to weight loss after dietary energy restriction. J Clin Endocrinol Metab 2005;90:5121-6.
52. Jang Y, Kim OY, Lee JH, Koh SJ, Chae JS, Kim JY, Park S, Cho H, Lee JE, Ordovas JM. Genetic variation at the perilipin locus is associated with changes in serum free fatty acids and abdominal fat following mild weight loss. Int. J Obes (Lond) 2006;30:1601-8.
53. Soenen S, Mariman EC, Vogels N, Bouwman FG, den Hoed M, Brown L, Westerterp-Plantenga MS. Relationship between perilipin gene polymorphisms and body weight and body composition during weight loss and weight maintenance. Physiol Behav 2009;96:723-8.
54. de Luis D, Aller R, Izaola O, Sagrado MG, de la Fuente B, Conde R, Primo D. Effect of fatty acid-binding protein 2 Ala54Thr genotype on weight loss and cardiovascular risk factors after a high-polyunsaturated fat diet in obese patients. J Investig Med 2012;60:1194-8.
55. Stocks T, Angquist L, Banasik K, Harder MN, Taylor MA, Hager J, Arner P, Oppert JM, Martinez JA, Polak J, et al. TFAP2B influences the effect of dietary fat on weight loss under energy restriction. PLoS One 2012;7:e43212.
56. Teng AC, Adamo K, Tesson F, Stewart AF. Functional characterization of a promoter polymorphism that drives ACSL5 gene expression in skeletal muscle and associates with diet-induced weight loss. FASEB J 2009;23:1705-9.
57. Smith CE, Ordovas JM. Update on perilipin polymorphisms and obesity. Nutr Rev 2012;70:611-21.
58. Storch J, Thumser AE. The fatty acid transport function of fatty acidbinding proteins. Biochim Biophys Acta 2000;1486:28-44.
59. Yu XH, Jiang N, Yao PB, Zheng XL, Cayabyab FS, Tang CK. NPC1, intracellular cholesterol trafficking and atherosclerosis. Clin Chim Acta 2014;429:69-75.
60. Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C, Glunk V, Sousa IS, Beaudry JL, Puviindran V, et al. FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. N Engl J Med 2015;373:895-907.
61. Zhang X, Qi Q, Zhang C, Smith SR, Hu FB, Sacks FM, Bray GA, Qi L. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Diabetes 2012;61:3005-11. Corrected in: Diabetes 2013;62:662.
62. Mitchell JA, Church TS, Rankinen T, Earnest CP, Sui X, Blair SN. FTO genotype and the weight loss benefits of moderate intensity exercise. Obesity (Silver Spring) 2010;18:641-3.
63. de Luis DA, Aller R, Conde R, Izaola O, Gonzalez Sagrado M, Castrodeza Sanz J. The rs9939609 gene variant in FTO modified the metabolic response of weight loss after a 3-month intervention with a hypocaloric diet. J Investig Med 2013;61:22-6.
64. Grau K, Hansen T, Holst C, Astrup A, Saris WH, Arner P, Rossner S, Macdonald I, Polak J, Oppert JM, et al. Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans. Int J Obes (Lond) 2009;33:1227-34.
65. Huang T, Qi Q, Li Y, Hu FB, Bray GA, Sacks FM, Williamson DA, Qi L. FTO genotype, dietary protein, and change in appetite: The Preventing Overweight Using Novel Dietary Strategies trial. Am J Clin Nutr 2014;99:1126-30.
66. Qi Q, Bray GA, Smith SR, Hu FB, Sacks FM, Qi L. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation 2011;124:563-71.
67. Schmitz-Peiffer C, Whitehead JP. IRS-1 regulation in health and disease. IUBMB Life 2003;55:367-74.
68. Gómez-Abellán P, Madrid JA, Ordovas JM, Garaulet M. Chronobiological aspects of obesity and metabolic syndrome. Endocrinol Nutr 2012;59:50-61.
69. Garaulet M, Sanchez-Moreno C, Smith CE, Lee YC, Nicolas F, Ordovas JM. Ghrelin, sleep reduction and evening preference: relationships to CLOCK 3111 T/C SNP and weight loss. PLoS One 2011;6:e17435.
70. McGowan PO, Szyf M. The epigenetics of social adversity in early life: implications for mental health outcomes. Neurobiol Dis 2010;39: 66-72.
71. Goni L, Milagro FI, Cuervo M, Martinez JA. Single-nucleotide polymorphisms and DNA methylation markers associated with central obesity and regulation of body weight. Nutr Rev 2014;72:673-90.
72. Campion J, Milagro FI, Goyenechea E, Martinez JA. TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver Spring) 2009;17:1293-7.
73. Cordero P, Campion J, Milagro FI, Goyenechea E, Steemburgo T, Javierre BM, Martinez JA. Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J Physiol Biochem 2011;67:463-70.
74. Abete I, Gomez-Uriz AM, Mansego ML, De Arce A, Goyenechea E, Blazquez V, Martinez-Zabaleta MT, Gonzalez-Muniesa P, Lopez De Munain A, Martinez JA, Campion J, Milagro FI. Epigenetic changes in the methylation patterns of KCNQ1 and WT1 after a weight loss intervention program in obese stroke patients. Curr Neurovasc Res 2015;12:321-33.
75. Bouchard L, Rabasa-Lhoret R, Faraj M, Lavoie ME, Mill J, Perusse L, Vohl MC. Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. Am J Clin Nutr 2010;91:309-20.
76. Milagro FI, Campion J, Cordero P, Goyenechea E, Gomez-Uriz AM, Abete I, Zulet MA, Martinez JA. A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to dietinduced weight loss. FASEB J 2011;25:1378-89.
77. Milagro FI, Gomez-Abellan P, Campion J, Martinez JA, Ordovas JM, Garaulet M. CLOCK, PER2 and BMAL1 DNA methylation: Association with obesity and metabolic syndrome characteristics and monounsaturated fat intake. Chronobiol Int 2012;29:1180-94.
78. Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuno MI. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol 2014;5:190.
79. Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspects Med 2013;34:39-58.
80. Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008;88:894-9.
81. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, Hardt PD. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010;18:190-5.
82. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, et al. MetaHIT consortium, Bork P, Wang J, Ehrlich SD, Pedersen O. Richness of human gut microbiome correlates with metabolic markers. Nature 2013;500:541-6.
83. Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, Almeida M, Quinquis B, Levenez F, Galleron N, et al. ANR MicroObes consortium, Dore J, Zucker JD, Clement K, Ehrlich SD. Dietary intervention impact on gut microbial gene richness. Nature 2013;500: 585-8.
84. Kong LC, Wuillemin PH, Bastard JP, Sokolovska N, Gougis S, Fellahi S, Darakhshan F, Bonnefont-Rousselot D, Bittar R, Dore J, et al. Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach. Am J Clin Nutr 2013;98:1385-94.
85. Xiao S, Fei N, Pang X, Shen J, Wang L, Zhang B, Zhang M, Zhang X, Zhang C, Li M, et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol 2014;87:357-67.
86. Korpela K, Flint HJ, Johnstone AM, Lappi J, Poutanen K, Dewulf E, Delzenne N, de Vos WM, Salonen A. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS One 2014;9:e90702.
87. Remely M, Tesar I, Hippe B, Gnauer S, Rust P, Haslberger AG. Gut microbiota composition correlates with changes in body fat content due to weight loss. Benef Microbes 2015:1-9.
88. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008;32:1431-7.
89. Xu M, Qi Q, Liang J, Bray GA, Hu FB, Sacks FM, Qi L. Genetic determinant for amino acid metabolites and changes in body weight and insulin resistance in response to weight-loss diets: The Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation 2013;127:1283-9.
90. Kilpeläinen TO, Qi L, Brage S, Sharp SJ, Sonestedt E, Demerath E, Ahmad T, Mora S, Kaakinen M, Sandholt CH, et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med 2011;8:e1001116.
91. Moonesinghe R, Liu T, Khoury MJ. Evaluation of the discriminative accuracy of genomic profiling in the prediction of common complex diseases. Eur J Hum Genet 2010;18:485-9.
92. Goni L, Cuervo M, Milagro FI, Martinez JA. A genetic risk tool for obesity predisposition assessment and personalized nutrition implementation based on macronutrient intake. Genes Nutr 2015;10:445.
93. Kumar H, Lund R, Laiho A, Lundelin K, Ley RE, Isolauri E, Salminen S. Gut microbiota as an epigenetic regulator: Pilot study based on wholegenome methylation analysis. MBio 2014;5:10.
94. Peters SP. Reporting and evaluating genetic association studies. Respir Res 2009;10:109.